This site is intended for health professionals only

At the heart of general practice since 1960

Read the latest issue online

Gold, incentives and meh

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Your comments will be sent to our moderator for review.

Report comment to moderator

Required fields.


NICE expensive drug approvals ‘doing more harm than good’


From the study abstract: "the limitation of currently available data means that there is substantial uncertainty associated with the estimate of the overall threshold (for each QALY gained)." My humble thoughts are that this study is very tentative and makes some (at least partially) unfounded assumptions. The researchers seem to describe it as a first go at estimating a benchmark but admit there are significant limitations. In that case I do not think it deserves the publicity it has received and health policy should not be influenced by such insubstantial research. But there is a General Election looming and all sorts of dubious claims are being touted as fact.

Posted date

20 Feb 2015

Posted time